PharmaShots Weekly Snapshots (November 09-13, 2020)
Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US
Published: Nov 13,2020 | Tags: Antigen Test, Digital, Launches, Portable, Qiagen, SARS-CoV-2, US
GSK and Medicago Initiate P-II/III Study of its Plant-Derived COVID-19 Vaccine
Published: Nov 13,2020 | Tags: COVID-19, GSK, Initiate, Medicago, P-II/III, Plant- Derived study, vaccine
BD Acquires the Medical Business Assets of CUBEX
Published: Nov 13, 2020 | Tags: BD, Acquires, Medical Business, Assets, CUBEX
Health2Sync Divulges Benefits of Integrating Fitbit Wearable Devices into Diabetes Care in Taiwan
Published: Nov 13,2020 | Tags: Health2Sync, Divulges, Benefits, Integrating, Fitbit, Wearable Devices, Diabetes, Care, Taiwan
UCB Acquires Handl Therapeutics to Augment its Gene Therapy Portfolio
Published: Nov 13,2020 | Tags: UCB, Acquires, Handl Therapeutics, Augment, Gene Therapy, Portfolio
Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI
Published: Nov 13,2020 | Tags: CGM Data, Diabetes, InPen, Integrated, Launches, MDI, Medtronic
Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test
Published: Nov 12,2020 | Tags: COVID-19, Exclusive, License Agreement, Option, Qiagen, Research, Signs, TScan Therapeutics
Published: Nov 12,2020 | Tags: acalabrutinib, AstraZenca, CALAVI, Calquence, COVID-19, P-ll Study, Report, Respiratory Complications, results
Pfizer and BioNTech to Supply EU with up to 200M Doses of BNT162B2 Against COVID-19
Published: Nov 12,2020 | Tags: Agreement, BioNTech, BNT162b2, EU, European Commission, m-RNA Vaccine, Pfizer, Signs, Supply
Pfizer Reports Results of Abrocitinib in Fifth P-lll JADE REGIMEN Across Different Dosing Regimens
Published: Nov 12,2020 | Tags: Abrocitinib, JADE REGIMEN Study, moderate to severe Atopic Dermatitis (AD), P-lll, Pfizer, Positive, Report, results
Moderna Report Results of mRNA-4157 + Keytruda in Interim P-l Study for HNSCC and MSS-CRC
Published: Nov 12,2020 | Tags: HNSCC, Interim, Moderna, mRNA-4157, P-l study, pembrolizumab, Report, results, SITC 2020
J&J Resumes all Clinical Trial of its COVID-19 Vaccine in the EU
Published: Nov 12,2020 | Tags: Clinical Trial, COVID-19, EU, J&J, Resumes, vaccine
CureVac Publishes Results of CVnCoV in Interim P-l Study for COVID-19
Published: Nov 11,2020 | Tags: COVID-19, CureVac, CVnCoV, Interim, P-l study, reports, results
Published: Nov 11,2020 | Tags: Agreement, Biosimilar, Commercialize, Israel, Prestige, Signs, Teva, trastuzumab, Tuznue
Published: Nov 11,2020 | Tags: Designed, Marketing, New Device, Nightmare Disorder, Permit, PTSD, Reduce, Sleep, US FDA
Samsung Bioepis Initiates P-I Study of SB16 Proposed Biosimilar to Prolia (denosumab)
Published: Nov 11,2020 | Tags: (Denosumab), Initiates, P-I study, Prolia, Proposed Biosimilar, Samsung Bioepis, SB16
Abbott Launches IonicRF Generator for Patients with Chronic Pain in the US
Published: Nov 11,2020 | Tags: Abbott, Chronic, Generator, IonicRF, Launch, Pain, patients, US, Use
Henlius Reports First Patients Dosing in P-I Study of HLX14 (denosumab, biosimilar)
Published: Nov 11,2020 | Tags: Henlius, Reports, First, Patient Dosing, P-l Study, HLX14, denosumab, biosimilar
Novavax Receives the US FDA's Fast Track Designation for NVX-CoV2373 to Treat COVID-19
Published: Nov 10, 2020 | Tags: COVID-19, Fast Track Designation, Novavax, NVX-CoV2373, receives, Treat, US FDA
AstraZeneca and Amgen Report Results of Tezepelumab in P-III NAVIGATOR for Asthma
Published: Nov 10,2020 | Tags: Amgen, Asthma, AstraZeneca, NAVIGATOR, P-III, patients, Positive, reports, results, Severe, Tezepelumab, Trial, Uncontrolled
Published: Nov 10,2020 | Tags: Bamlanivimab, COVID-19, Diagnosed, EUA, Lilly, LY-CoV555, receives, recently, Treatment, Us FDA
Pfizer and BioNTech's BNT16`2b2 Demonstrates 90% Efficacy in Preventing COVID-19
Published: Nov 10,2020 | Tags: Against, BioNTech, BNT162b2, Clinical, Pfizer, reports, study
AstraZeneca's Calquence (acalabrutinib) Receives EU's Approval for Chronic Lymphocytic Leukaemia
Published: Nov 10,2020 | Tags: (acalabrutinib), AstraZeneca's, Calquence, Chronic Lymphocytic Leukaemia (CLL), EUs Approval, receives
Bayer Reports Regulatory Submission of Finerenone (BAY 94-8862) to the US and EU for CKD and T2D
Published: Nov 10,2020 | Tags: (BAY 94-8862), Bayer, EMA, Finerenone, Regulatory Applications, Submits, Treat Chronic Kidney Disease (CKD), Type 2 Diabetes (T2D), Us FDA
Alvotech and Cipla Collaborate to Ensure Access to Biosimilars in South Africa
Published: Nov 9,2020 | Tags: Access, Alvotech, Biosimilars, Cipla, Ensure, Exclusive Partnership, Expand, South Africa
Published: Nov 9,2020 | Tags: (canakinumab), CAN-COVID Trial, Covid-19, Pneumonia, Cytokine Release Syndrome (CRS), Ilaris, Novartis, P-lll, Report, results
Published: Nov 9,2020 | Tags: 2020, 218, Advanced, Renal, Cell, Carcinoma, Eisai, Everolimus, IKCS, lenvatinib, Lenvima, P-II, Presents, results, study
Celltrion Reports Results of CT-P59 in P-I Study for COVID-19
Published: Nov 9, 2020 | Tags: 2020, Celltrion, Clinical, Conference, CT-P59, Fall, Korean Society of Infectious Diseases, P-I, Presents, results, Trial
The US FDA's Advisory Panel Slams Biogen's Aducanumab for Alzheimer's Disease
Published: Nov 9, 2020 | Tags: aducanumab, Advisory, Biogen, Committee, EMERGE, ENGAGE, Meeting, P-III, reports, study, Updates, Us FDA
Merck and Transcenta Collaborate to Implement Continuous Manufacturing for Protein Therapeutics
Published: Nov 9, 2020 | Tags: Collaborate, Continuous Manufacturing, Implement, Merck, Protein Therapeutics, Transcenta
Related Post: PharmaShots Weekly Snapshot (Nov 02-06, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
